Literature DB >> 2847613

Epstein-Barr virus in the bone marrow of patients with aplastic anemia.

B Baranski1, G Armstrong, J T Truman, G V Quinnan, S E Straus, N S Young.   

Abstract

STUDY
OBJECTIVE: To determine whether Epstein-Barr virus is present in the bone marrow of patients with aplastic anemia.
DESIGN: Assay of fresh and fixed bone marrow specimens for Epstein-Barr virus using immunofluorescence for nuclear antigen, Southern analysis with an Epstein-Barr virus specific probe, and in-situ hybridization.
SETTING: Governmental medical referral center. PATIENTS: Five patients were studied prospectively: three who previously had infectious mononucleosis, one with a recent viral pneumonitis, and one who was asymptomatic. Stored DNA samples from other patients with aplastic anemia were also screened.
MEASUREMENTS AND MAIN RESULTS: Epstein-Barr virus DNA and protein were detected in the bone marrow of 5 patients studied prospectively and in 1 of 40 patients studied retrospectively. As estimated by in-situ hybridization, about 3% to 5% of marrow cells were infected with virus in those patients who had not received acyclovir. In contrast, Epstein-Barr virus DNA was not detected in peripheral blood DNA of these patients, nor were Epstein-Barr virus proteins or DNA found in the bone marrow of normal donors, patients with other hematologic diseases, or in 1 patient with acute infectious mononucleosis. Analysis of DNA fragments by hybridization with Epstein-Barr virus probes showed a pattern dissimilar to the type of Epstein-Barr virus usually associated with infectious mononucleosis.
CONCLUSIONS: Aplastic anemia may be associated with Epstein-Barr virus more commonly than suspected by history. Localization of the virus in the bone marrow supports a causative role for Epstein-Barr virus in bone marrow failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847613     DOI: 10.7326/0003-4819-109-9-695

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

Review 1.  How I treat acquired aplastic anemia.

Authors:  Phillip Scheinberg; Neal S Young
Journal:  Blood       Date:  2012-04-19       Impact factor: 22.113

Review 2.  The significance of substance P in physiological and malignant haematopoiesis.

Authors:  Michal Nowicki; Danuta Ostalska-Nowicka; Beata Kondraciuk; Bogdan Miskowiak
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

Review 3.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

4.  The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.

Authors:  M Nowicki; D Ostalska-Nowicka; A Konwerska; B Miskowiak
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

5.  The epidemiology of aplastic anemia in Thailand.

Authors:  Surapol Issaragrisil; David W Kaufman; Theresa Anderson; Kanchana Chansung; Paul E Leaverton; Samuel Shapiro; Neal S Young
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia.

Authors:  Phillip Scheinberg; Steven H Fischer; Li Li; Olga Nunez; Colin O Wu; Elaine M Sloand; Jeffrey I Cohen; Neal S Young; A John Barrett
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

7.  Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus.

Authors:  K Xie; M Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

8.  Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.

Authors:  M Levy; J P Kelly; D W Kaufman; S Shapiro
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

9.  Pure red cell aplasia in a patient with trisomy X chromosome abnormality and reactivated Epstein-Barr virus infection.

Authors:  Masanori Daibata; Hisanori Machida; Yuiko Nemoto; Hirokuni Taguchi
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

10.  Increased formation of DNA adducts in cultured fibroblasts of patients with aplastic anemia after in vitro incubation with benzo(a)pyrene.

Authors:  A Meyer; D Nowak; D Hossfeld; H W Rüdiger
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.